Dolutegravir-based antiretroviraltherapies for HIV-1 effective in pregnancy HarvardChanSPH nejm
, small for gestational age, or neonatal death) between dolutegravir-based regimens and the other contemporary regimens.
Dolutegravir, a more recently approved antiretroviral drug, is part of a once-a-day regimen that has been shown to be more effective, easier to tolerate, and less likely to create new drug resistance in people with HIV-1 compared with other. However, limited data have been available about its effectiveness and safety in pregnancy compared with regimens that commonly have been used during pregnancy in the U.S. and Europe.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Herbar: new Berlin beauty brand combines art and adaptogensHerbar is a Berlin beauty line for all ages and skin types that harnesses adaptogenic mushrooms and plants for its products, and local artists for its branding
Consulte Mais informação »
Onitsuka Tiger’s London store fuses fashion and contemporary artJapanese sports-inspired fashion brand Onitsuka Tiger announces a contemporary art programme at its West End store
Consulte Mais informação »
Princess DianaA thought-provoking blend of high fashion, art and culture brought to you by the creators of AnOther Magazine
Consulte Mais informação »
What’s not safe to eat in pregnancy?Unsafe food during pregnancy - we spoke to a range of nutrition and pregnancy experts to find out which foods are best to avoid during pregnancy.
Consulte Mais informação »
Redshift Arclight Bike PedalsReview: Redshift Arclight Bike Pedals - not the cheapest way to add lights, but surprisingly bright & very effective cycling RedShiftSports
Consulte Mais informação »
In-Hospital Mortality Among Pregnant and Postpartum Individuals by Pregnancy PeriodThis cross-sectional study investigates trends in death rates and proportion of deaths by pregnancy period among pregnant and postpartum individuals from 1994 to 2019.
Consulte Mais informação »